CGTX - Cognition Therapeutics, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
1.74 0.1 (5.75%)	0.0 (0.0%)	0.0 (0.0%)	0.0 (0.0%)	0.01 (0.29%)	0.07 (4.01%)	0.03 (1.66%)	0.03 (1.66%)

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.11
Diluted EPS:: -0.11
Basic P/E:: -16.7273
Diluted P/E:: -16.7273
RSI(14) 1m:: 100.0
VWAP:: 1.84
RVol:: 0.4617

Events

Period	Kind	Movement	Occurred At
1m	Price decrease 1m	1.77 -0.02 (-1.12%)	Oct 15 11:52
1m	Price decrease 1m	1.79 -0.03 (-1.65%)	Oct 15 11:34
1m	Price increase 1m	1.85 +0.02 (+1.09%)	Oct 15 10:51
1m	Price increase 1m	1.82 +0.03 (+1.68%)	Oct 15 09:44
1m	Price decrease 1m	1.77 -0.02 (-1.39%)	Oct 15 09:39